Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TECH

BIO-TECHNE Corp

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 842023Held by 13 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2026
$1.22B
Net Income FY2026
$0.18B
EPS (Basic, as reported)
$1.17
Net Margin FY2026
15.0%
ROE FY2026
8.6%
Total Equity
$2.11B
Shares Out
157M
Business description

BIO-TECHNE Corp — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 563 → 1,215 +8.9% CAGR
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023FY2024FY2025FY2026
Revenue5636437147399311,1061,1371,1591,2201,215
Cost of revenue(188)(211)(241)(255)(298)(349)(367)(389)(429)(416)
Gross profit375432473483633756770770790799
Selling, general & administrative(200)(241)(264)(261)(325)(373)(378)(466)(589)(452)
Total operating expenses(254)(296)(327)(326)(396)(460)(471)(563)(688)(547)
Operating income121136147157237297299207102252
Interest expense(7)(10)(22)(19)(14)(11)(11)(16)(9)(10)
Interest & investment income——————3344
Other income (expense), net(9)(10)(35)119(89)540(21)(4)(11)
Pre-tax income11212611227614830133918698241
Income tax expense(36)0(16)(47)(9)(38)(53)(18)(25)(59)
Net income761269622914027228516873182
EPS — basic$2.04$3.36$2.54$6.00$3.62$6.93$1.81$1.07$0.47$1.17
EPS — diluted$2.03$3.31$2.47$5.82$3.47$6.63$1.76$1.05$0.46$1.16
Shares outstanding — basic (M)373738383939157158158156
Shares outstanding — diluted (M)383839394041162161160157

Showing the latest 10 of 18 fiscal years.

  • ⚑ Weighted-average shares changed ×4.03 between FY2022 and FY2023 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.